PT  - JOURNAL ARTICLE
AU  - Jain, Anu
AU  - Cole, Michelle J
AU  - Planche, Tim
AU  - Ison, Catherine A
TI  - An evaluation of <em>Neisseria gonorrhoeae</em> antimicrobial susceptibility testing in the UK
AID  - 10.1136/jclinpath-2014-202392
DP  - 2014 Nov 01
TA  - Journal of Clinical Pathology
PG  - 1013--1016
VI  - 67
IP  - 11
4099  - http://jcp.bmj.com/content/67/11/1013.short
4100  - http://jcp.bmj.com/content/67/11/1013.full
SO  - J Clin Pathol2014 Nov 01; 67
AB  - The only method currently available to perform Neisseria gonorrhoeae antimicrobial susceptibility testing (Ng-AST) requires a viable organism obtained by culture. Reports of in vitro resistance to extended-spectrum cephalosporins, the treatment of choice for gonorrhoea, coupled with increasing gonorrhoea diagnoses is worrying. The aim of this study was to identify various methodologies employed by the UK microbiology laboratories to perform Ng-AST. Of the 118 laboratories that responded, 114 offered Ng-AST; the majority (82.5%, 94/114) of the laboratories used British Society for Antimicrobial Chemotherapy methodology for Ng-AST. The other main findings were infrequent use of quality control procedures and inconsistent susceptibility testing of the antibiotics used routinely for treatment.